BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10573782)

  • 1. Subtypes in monosymptomatic nocturnal enuresis. II.
    van Gool JD; Nieuwenhuis E; ten Doeschate IO; Messer TP; de Jong TP
    Scand J Urol Nephrol Suppl; 1999; 202():8-11. PubMed ID: 10573782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and treatment of enuresis in adults.
    Robertson G; Rittig S; Kovacs L; Gaskill MB; Zee P; Nanninga J
    Scand J Urol Nephrol Suppl; 1999; 202():36-8; discussion 38-9. PubMed ID: 10573790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
    Mello MF; Locali RF; Araujo RM; Reis JN; Saiovici S; Mello LF; Trigo Rocha FE
    J Pediatr Urol; 2023 Jun; 19(3):241-246. PubMed ID: 36717289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiology of monosymptomatic nocturnal enuresis with special emphasis on the circadian rhythm of renal physiology.
    Dossche L; Walle JV; Van Herzeele C
    Eur J Pediatr; 2016 Jun; 175(6):747-54. PubMed ID: 27138767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid deprivation in enuresis--effect on urine output and plasma arginine vasopressin.
    Hunsballe J; Rittig S; Pedersen EB; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1999; 202():50-1. PubMed ID: 10573794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
    Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options in childhood nocturnal enuresis.
    Zaffanello M; Giacomello L; Brugnara M; Fanos V
    Minerva Urol Nefrol; 2007 Jun; 59(2):199-205. PubMed ID: 17571056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal enuresis in children: The role of arginine-vasopressin.
    Kamperis K
    Handb Clin Neurol; 2021; 181():289-297. PubMed ID: 34238464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
    Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacodynamic study of desmopressin in patients with nocturnal enuresis.
    Nørgaard JP; Jønler M; Rittig S; Djurhuus JC
    J Urol; 1995 Jun; 153(6):1984-6. PubMed ID: 7752378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsatile release of arginine vasopressin (AVP) and it's effect on response to desmopressin in enuresis.
    Wood CM; Butler RJ; Penney MD; Holland PC
    Scand J Urol Nephrol Suppl; 1994; 163():93-101. PubMed ID: 7878390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
    Lee T; Suh HJ; Lee HJ; Lee JE
    J Urol; 2005 Sep; 174(3):1084-7. PubMed ID: 16094064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
    Rittig N; Hagstroem S; Mahler B; Kamperis K; Siggaard C; Mikkelsen MM; Bower WF; Djurhuus JC; Rittig S
    Neurourol Urodyn; 2014 Jun; 33(5):475-81. PubMed ID: 23765698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal polyuria is related to absent circadian rhythm of glomerular filtration rate.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Raes A; Donckerwolcke R; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2626-9. PubMed ID: 17945293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monosymptomatic bedwetting.
    Djurhuus JC; Nørgaard JP; Rittig S
    Scand J Urol Nephrol Suppl; 1992; 141():7-17; discussion 18-9. PubMed ID: 1609254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma vasopressin and response to treatment in primary nocturnal enuresis.
    Devitt H; Holland P; Butler R; Redfern E; Hiley E; Roberts G
    Arch Dis Child; 1999 May; 80(5):448-51. PubMed ID: 10208951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
    Kamperis K; Hagstroem S; Faerch M; Mahler B; Rittig S; Djurhuus JC
    Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of desmopressin fast-melting formulation and enuretic alarm in the treatment of monosymptomatic nocturnal enuresis.
    Keten T; Aslan Y; Balci M; Erkan A; Senel C; Oguz U; Kayali M; Guzel O; Karabulut E; Tuncel A
    J Pediatr Urol; 2020 Oct; 16(5):645.e1-645.e7. PubMed ID: 32826183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.